Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (7715)	1/12/2003 8:39:26 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 52153

Mike: Two out of the ~10 JPMHQ analysts said at the recent conference they really like TMCO. The only place to generate a vibrant conversation is on the thread. And if no one on SI is following it and you get no takers there, you are stuck with Yahoo. Generally, posters here do not respond about a company unless they already have a passing understanding. Sounds like TMCO has slipped between them. Plus, many of us are simply hoping angiomax does not in fact kill integrillin. Wilder